| Year |
Citation |
Score |
| 2023 |
Krzyzanowski B, Nielsen SS, Turner JR, Racette BA. Fine Particulate Matter and Parkinson Disease Risk Among Medicare Beneficiaries. Neurology. PMID 37903644 DOI: 10.1212/WNL.0000000000207871 |
0.365 |
|
| 2022 |
Martin WRW, Younce JR, Campbell MC, Racette BA, Norris SA, Ushe M, Criswell S, Davis AA, Alfradique-Dunham I, Maiti B, Cairns NJ, Perrin RJ, Kotzbauer PT, Perlmutter JS. Neocortical Lewy body pathology parallels Parkinson's dementia, but not always. Annals of Neurology. PMID 36331161 DOI: 10.1002/ana.26542 |
0.789 |
|
| 2022 |
Racette BA, Nelson G, Dlamini WW, Hershey T, Prathibha P, Turner JR, Checkoway H, Sheppard L, Searles Nielsen S. Environmental manganese exposure and cognitive control in a South African population. Neurotoxicology. 89: 31-40. PMID 34999155 DOI: 10.1016/j.neuro.2022.01.004 |
0.469 |
|
| 2021 |
Nielsen SS, Warden MN, Sallmén M, Sainio M, Uuksulainen S, Checkoway H, Hublin C, Racette BA. Solvent exposed occupations and risk of Parkinson disease in Finland. Clinical Parkinsonism & Related Disorders. 4: 100092. PMID 34316670 DOI: 10.1016/j.prdoa.2021.100092 |
0.34 |
|
| 2021 |
Racette BA, Nelson G, Dlamini WW, Hershey T, Prathibha P, Turner JR, Checkoway H, Sheppard L, Nielsen SS. Depression and anxiety in a manganese-exposed community. Neurotoxicology. PMID 34087333 DOI: 10.1016/j.neuro.2021.05.017 |
0.463 |
|
| 2021 |
Dlamini WW, Nielsen S, Ushe M, Nelson G, Racette BA. A Rapid Motor Task-Based Screening Tool for Parkinsonism in Community-Based Studies. Frontiers in Neurology. 12: 653066. PMID 34054697 DOI: 10.3389/fneur.2021.653066 |
0.738 |
|
| 2021 |
Racette BA, Nelson G, Dlamini WW, Prathibha P, Turner JR, Ushe M, Checkoway H, Sheppard L, Nielsen SS. Severity of parkinsonism associated with environmental manganese exposure. Environmental Health : a Global Access Science Source. 20: 27. PMID 33722243 DOI: 10.1186/s12940-021-00712-3 |
0.749 |
|
| 2020 |
Martin WRW, Miles M, Zhong Q, Hartlein J, Racette BA, Norris SA, Ushe M, Maiti B, Criswell S, Davis AA, Kotzbauer PT, Cairns NJ, Perrin RJ, Perlmutter JS. Is Levodopa Response a Valid Indicator of Parkinson's Disease? Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33253432 DOI: 10.1002/mds.28406 |
0.785 |
|
| 2020 |
Nelson G, Ndlovu N, Christofides N, Hlungwani TM, Faust I, Racette BA. Validation of Parkinson's Disease-Related Questionnaires in South Africa. Parkinson's Disease. 2020: 7542138. PMID 32617145 DOI: 10.1155/2020/7542138 |
0.336 |
|
| 2020 |
Criswell SR, Nielsen SS, Warden MN, Perlmutter JS, Moerlein SM, Sheppard L, Lenox-Krug J, Checkoway H, Racette BA. [11C]dihydrotetrabenazine Positron Emission Tomography in Manganese-Exposed Workers. Journal of Occupational and Environmental Medicine. PMID 32472844 DOI: 10.1097/Jom.0000000000001915 |
0.386 |
|
| 2020 |
Faust IM, Racette BA, Searles Nielsen S. Validation of a Parkinson Disease Predictive Model in a Population-Based Study. Parkinson's Disease. 2020: 2857608. PMID 32148753 DOI: 10.1155/2020/2857608 |
0.376 |
|
| 2020 |
Silver MR, Racette BA, Dube U, Faust IM, Searles Nielsen S. Well Water and Parkinson's Disease in Medicare Beneficiaries: A Nationwide Case-Control Study. Journal of Parkinson's Disease. PMID 32083591 DOI: 10.3233/Jpd-191793 |
0.349 |
|
| 2019 |
Fan J, Searles Nielsen S, Faust IM, Racette BA. Transplant and risk of Parkinson disease. Parkinsonism & Related Disorders. PMID 30827837 DOI: 10.1016/j.parkreldis.2019.02.013 |
0.303 |
|
| 2018 |
Criswell SR, Warden MN, Searles Nielsen S, Perlmutter JS, Moerlein SM, Sheppard L, Lenox-Krug J, Checkoway H, Racette BA. Selective D2 receptor PET in manganese-exposed workers. Neurology. PMID 30097475 DOI: 10.1212/Wnl.0000000000006163 |
0.423 |
|
| 2018 |
Camacho-Soto A, Gross A, Searles Nielsen S, Dey N, Racette BA. Inflammatory bowel disease and risk of Parkinson's disease in Medicare beneficiaries. Parkinsonism & Related Disorders. PMID 29459115 DOI: 10.1016/j.parkreldis.2018.02.008 |
0.379 |
|
| 2018 |
Racette BA. 1714a Parkinsonism predictive model in mn-exposed workers Occupational and Environmental Medicine. 75. DOI: 10.1136/Oemed-2018-Icohabstracts.825 |
0.373 |
|
| 2018 |
Racette BA. 1713d Occupational exposure to solvents and risk of parkinson disease in finland Occupational and Environmental Medicine. 75. DOI: 10.1136/Oemed-2018-Icohabstracts.810 |
0.466 |
|
| 2018 |
Nelson G, Racette BA. 1387 Correlation between clinical assessment of parkinsonism, self-reported symptoms and motor dysfunction in a manganese-exposed community Occupational and Environmental Medicine. 75. DOI: 10.1136/Oemed-2018-Icohabstracts.1450 |
0.442 |
|
| 2018 |
Dlamini WW, Nelson G, Racette BA. 1367 The association between parkinsonism and quality of life in south african manganese mine workers Occupational and Environmental Medicine. 75. DOI: 10.1136/Oemed-2018-Icohabstracts.1434 |
0.405 |
|
| 2018 |
Sallmén M, Warden M, Uuksulainen S, Racette B, Sainio M, Searles Nielsen S. Risk of Parkinson disease in agricultural occupations in Finland Revue D'éPidéMiologie Et De Santé Publique. 66: S264. DOI: 10.1016/J.Respe.2018.05.077 |
0.47 |
|
| 2017 |
Camacho-Soto A, Warden MN, Searles Nielsen S, Salter A, Brody DL, Prather H, Racette BA. Traumatic Brain Injury in the Prodromal Period of Parkinson Disease: A Large Epidemiological Study Using Medicare Data. Annals of Neurology. PMID 29024046 DOI: 10.1002/ana.25074 |
0.328 |
|
| 2017 |
Searles Nielsen S, Warden MN, Camacho-Soto A, Willis AW, Wright BA, Racette BA. A predictive model to identify Parkinson disease from administrative claims data. Neurology. PMID 28864676 DOI: 10.1212/WNL.0000000000004536 |
0.338 |
|
| 2017 |
Criswell SR, Nielsen SS, Warden M, Perlmutter JS, Moerlein SM, Flores HP, Huang J, Sheppard L, Seixas N, Checkoway H, Racette BA. [(18)F]FDOPA Positron Emission Tomography in Manganese-Exposed Workers. Neurotoxicology. PMID 28694016 DOI: 10.1016/J.Neuro.2017.07.004 |
0.548 |
|
| 2017 |
Racette BA, Gross A, Criswell SR, Checkoway H, Nielsen SS. A Screening Tool to Detect Clinical Manganese Neurotoxicity. Neurotoxicology. PMID 28274800 DOI: 10.1016/J.Neuro.2017.02.009 |
0.373 |
|
| 2017 |
Martin WR, Hartlein J, Racette BA, Cairns N, Perlmutter JS. Pathologic correlates of supranuclear gaze palsy with parkinsonism. Parkinsonism & Related Disorders. PMID 28256434 DOI: 10.1016/J.Parkreldis.2017.02.027 |
0.553 |
|
| 2016 |
Racette BA, Searles Nielsen S, Criswell SR, Sheppard L, Seixas N, Warden MN, Checkoway H. Dose-dependent progression of parkinsonism in manganese-exposed welders. Neurology. PMID 28031394 DOI: 10.1212/Wnl.0000000000003533 |
0.341 |
|
| 2016 |
Al-Lozi A, Nielsen SS, Hershey T, Birke A, Checkoway H, Criswell SR, Racette BA. Cognitive control dysfunction in workers exposed to manganese-containing welding fume. American Journal of Industrial Medicine. PMID 27862095 DOI: 10.1002/Ajim.22675 |
0.53 |
|
| 2016 |
Davis AA, Racette B. Parkinson disease and cognitive impairment: Five new things. Neurology. Clinical Practice. 6: 452-458. PMID 27847686 DOI: 10.1212/CPJ.0000000000000285 |
0.302 |
|
| 2016 |
Nelson G, Racette B. P205 Measuring the health effects of manganese smelter emissions in south africa: a pilot study Occupational and Environmental Medicine. 73. DOI: 10.1136/Oemed-2016-103951.521 |
0.365 |
|
| 2015 |
Davis AA, Andruska KM, Benitez BA, Racette BA, Perlmutter JS, Cruchaga C. Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression. Neurobiology of Aging. PMID 26601739 DOI: 10.1016/J.Neurobiolaging.2015.09.014 |
0.638 |
|
| 2015 |
Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, Zhao H, Romer M, Young A, Hersch S, Penney J, Marder K, Paulsen J, Quaid K, ... ... Racette B, et al. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials. Jama Neurology. 1-9. PMID 26569098 DOI: 10.1001/Jamaneurol.2015.2736 |
0.432 |
|
| 2015 |
Safarpour D, Thibault DP, DeSanto CL, Boyd CM, Dorsey ER, Racette BA, Willis AW. Nursing home and end-of-life care in Parkinson disease. Neurology. 85: 413-9. PMID 26138947 DOI: 10.1212/Wnl.0000000000001715 |
0.332 |
|
| 2015 |
Racette BA, Willis AW. Time to change the blind men and the elephant approach to Parkinson disease? Neurology. 85: 190-6. PMID 26070339 DOI: 10.1212/Wnl.0000000000001739 |
0.393 |
|
| 2015 |
Low PA, Reich SG, Jankovic J, Shults CW, Stern MB, Novak P, Tanner CM, Gilman S, Marshall FJ, Wooten F, Racette B, Chelimsky T, Singer W, Sletten DM, Sandroni P, et al. Natural history of multiple system atrophy in the USA: a prospective cohort study. The Lancet. Neurology. 14: 710-9. PMID 26025783 DOI: 10.1016/S1474-4422(15)00058-7 |
0.303 |
|
| 2015 |
Checkoway H, Nielsen SS, Racette BA. Epidemiological studies of parkinsonism in welders Issues in Toxicology. 2015: 513-523. |
0.37 |
|
| 2014 |
Lundin JI, Ton TG, LaCroix AZ, Longstreth WT, Franklin GM, Swanson PD, Smith-Weller T, Racette BA, Checkoway H. Formulations of hormone therapy and risk of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1631-6. PMID 25255692 DOI: 10.1002/Mds.26037 |
0.357 |
|
| 2014 |
Vemula SR, Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Truong DD, Blitzer A, Rudzi?ska M, Mom?ilovi? D, et al. A rare sequence variant in intron 1 of THAP1 is associated with primary dystonia. Molecular Genetics & Genomic Medicine. 2: 261-72. PMID 24936516 DOI: 10.1002/Mgg3.67 |
0.467 |
|
| 2014 |
Harris-Hayes M, Willis AW, Klein SE, Czuppon S, Crowner B, Racette BA. Relative mortality in U.S. Medicare beneficiaries with Parkinson disease and hip and pelvic fractures. The Journal of Bone and Joint Surgery. American Volume. 96: e27. PMID 24553896 DOI: 10.2106/Jbjs.L.01317 |
0.319 |
|
| 2014 |
Gonzalez-Cuyar LF, Nelson G, Criswell SR, Ho P, Lonzanida JA, Checkoway H, Seixas N, Gelman BB, Evanoff BA, Murray J, Zhang J, Racette BA. Quantitative neuropathology associated with chronic manganese exposure in South African mine workers. Neurotoxicology. 45: 260-6. PMID 24374477 DOI: 10.1016/J.Neuro.2013.12.008 |
0.316 |
|
| 2014 |
Willis AW, Schootman M, Kung N, Wang XY, Perlmutter JS, Racette BA. Disparities in deep brain stimulation surgery among insured elders with Parkinson disease. Neurology. 82: 163-71. PMID 24336138 DOI: 10.1212/Wnl.0000000000000017 |
0.595 |
|
| 2014 |
Racette BA. Manganism in the 21st century: the Hanninen lecture. Neurotoxicology. 45: 201-7. PMID 24148923 DOI: 10.1016/J.Neuro.2013.09.007 |
0.47 |
|
| 2014 |
Lundin JI, Checkoway H, Criswell SR, Hobson AJ, Harris RC, Swisher LM, Evanoff BA, Racette BA. Screening for early detection of parkinsonism using a self-administered questionnaire: a cross-sectional epidemiologic study. Neurotoxicology. 45: 232-7. PMID 24035927 DOI: 10.1016/J.Neuro.2013.08.010 |
0.31 |
|
| 2014 |
Nielsen S, Checkoway H, Criswell S, Farin F, Racette B. 0239 Inducible nitric oxide synthase gene methylation and parkinsonism in manganese-exposed welders0239 Inducible nitric oxide synthase gene methylation and parkinsonism in manganese-exposed welders Occupational and Environmental Medicine. 71: A32.2-A32. DOI: 10.1136/Oemed-2014-102362.100 |
0.334 |
|
| 2013 |
Nichols MJ, Hartlein JM, Eicken MG, Racette BA, Black KJ. A fixed-dose randomized controlled trial of olanzapine for psychosis in Parkinson disease. F1000research. 2: 150. PMID 24627787 DOI: 10.12688/F1000Research.2-150.V1 |
0.625 |
|
| 2013 |
Harms MB, Neumann D, Benitez BA, Cooper B, Carrell D, Racette BA, Perlmutter JS, Goate A, Cruchaga C. Parkinson disease is not associated with C9ORF72 repeat expansions. Neurobiology of Aging. 34: 1519.e1-2. PMID 23116878 DOI: 10.1016/J.Neurobiolaging.2012.10.001 |
0.64 |
|
| 2013 |
Willis AW, Schootman M, Kung N, Racette BA. Epidemiology and neuropsychiatric manifestations of Young Onset Parkinson's Disease in the United States Parkinsonism and Related Disorders. 19: 202-206. PMID 23083512 DOI: 10.1016/J.Parkreldis.2012.09.014 |
0.362 |
|
| 2012 |
Lin X, Cook TJ, Zabetian CP, Leverenz JB, Peskind ER, Hu SC, Cain KC, Pan C, Edgar JS, Goodlett DR, Racette BA, Checkoway H, Montine TJ, Shi M, Zhang J. DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease. Scientific Reports. 2: 954. PMID 23233873 DOI: 10.1038/Srep00954 |
0.412 |
|
| 2012 |
Willis AW, Schootman M, Tran R, Kung N, Evanoff BA, Perlmutter JS, Racette BA. Neurologist-associated reduction in PD-related hospitalizations and health care expenditures. Neurology. 79: 1774-80. PMID 23054239 DOI: 10.1212/Wnl.0B013E3182703F92 |
0.608 |
|
| 2012 |
Racette BA, Criswell SR, Lundin JI, Hobson A, Seixas N, Kotzbauer PT, Evanoff BA, Perlmutter JS, Zhang J, Sheppard L, Checkoway H. Increased risk of parkinsonism associated with welding exposure. Neurotoxicology. 33: 1356-61. PMID 22975422 DOI: 10.1016/J.Neuro.2012.08.011 |
0.645 |
|
| 2012 |
Kotzbauer PT, Cairns NJ, Campbell MC, Willis AW, Racette BA, Tabbal SD, Perlmutter JS. Pathologic accumulation of α-synuclein and Aβ in Parkinson disease patients with dementia. Archives of Neurology. 69: 1326-31. PMID 22825369 DOI: 10.1001/Archneurol.2012.1608 |
0.622 |
|
| 2012 |
Criswell SR, Perlmutter JS, Huang JL, Golchin N, Flores HP, Hobson A, Aschner M, Erikson KM, Checkoway H, Racette BA. Basal ganglia intensity indices and diffusion weighted imaging in manganese-exposed welders. Occupational and Environmental Medicine. 69: 437-43. PMID 22447645 DOI: 10.1136/Oemed-2011-100119 |
0.491 |
|
| 2012 |
Criswell SR, Perlmutter JS, Crippin JS, Videen TO, Moerlein SM, Flores HP, Birke AM, Racette BA. Reduced uptake of FDOPA PET in end-stage liver disease with elevated manganese levels. Archives of Neurology. 69: 394-7. PMID 22410448 DOI: 10.1001/Archneurol.2011.771 |
0.543 |
|
| 2012 |
Willis AW, Schootman M, Kung N, Evanoff BA, Perlmutter JS, Racette BA. Predictors of survival in patients with Parkinson disease. Archives of Neurology. 69: 601-7. PMID 22213411 DOI: 10.1001/Archneurol.2011.2370 |
0.627 |
|
| 2012 |
Racette BA, Aschner M, Guilarte TR, Dydak U, Criswell SR, Zheng W. Pathophysiology of manganese-associated neurotoxicity. Neurotoxicology. 33: 881-6. PMID 22202748 DOI: 10.1016/J.Neuro.2011.12.010 |
0.379 |
|
| 2012 |
Wright Willis A, Schootman M, Perlmutter J, Racette B. Neurologist Care in PD Is Associated with Fewer PD Related Hospitalizations (P02.242) Neurology. 78: P02.242-P02.242. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P02.242 |
0.594 |
|
| 2011 |
Zhu L, Cairns NJ, Tabbal SD, Racette BA. Pregnancy in multiple system atrophy: a case report. Journal of Medical Case Reports. 5: 599. PMID 22208291 DOI: 10.1186/1752-1947-5-599 |
0.37 |
|
| 2011 |
Willis AW, Schootman M, Evanoff BA, Perlmutter JS, Racette BA. Neurologist care in Parkinson disease: A utilization, outcomes, and survival study Neurology. 77: 851-857. PMID 21832214 DOI: 10.1212/Wnl.0B013E31822C9123 |
0.601 |
|
| 2011 |
Criswell SR, Perlmutter JS, Videen TO, Moerlein SM, Flores HP, Birke AM, Racette BA. Reduced uptake of [¹⁸F]FDOPA PET in asymptomatic welders with occupational manganese exposure. Neurology. 76: 1296-301. PMID 21471467 DOI: 10.1212/Wnl.0B013E3182152830 |
0.539 |
|
| 2011 |
Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Simon DK, Tarsy D, Hedera P, Truong DD, et al. The c.-237_236GA>TT THAP1 sequence variant does not increase risk for primary dystonia. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 549-52. PMID 21370264 DOI: 10.1002/Mds.23551 |
0.488 |
|
| 2011 |
Criswell SR, Perlmutter JS, Videen TO, Moerlein SM, Flores HP, Birke AM, Racette BA. Reduced uptake of [18F]FDOPA PET in asymptomatic welders with occupational manganese exposure Neurology. 76: 1296-1301. DOI: 10.1212/WNL.0b013e3182152830 |
0.441 |
|
| 2011 |
Lundin J, Checkoway H, Criswell S, Hobson A, Seixas N, Evanoff B, Sheppard L, Racette B. Increased risk of Parkinsonism associated with cumulative hours of welding Occupational and Environmental Medicine. 68: A7-A7. DOI: 10.1136/Oemed-2011-100382.20 |
0.395 |
|
| 2010 |
Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, et al. Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6. Human Genetics. 127: 470. PMID 21488297 |
0.425 |
|
| 2010 |
Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, et al. Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6. Human Genetics. 127: 469. PMID 21488277 |
0.425 |
|
| 2010 |
Willis AW, Evanoff BA, Lian M, Galarza A, Wegrzyn A, Schootman M, Racette BA. Metal emissions and urban incident Parkinson disease: a community health study of Medicare beneficiaries by using geographic information systems. American Journal of Epidemiology. 172: 1357-63. PMID 20959505 DOI: 10.1093/Aje/Kwq303 |
0.38 |
|
| 2010 |
Wright Willis A, Evanoff BA, Lian M, Criswell SR, Racette BA. Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries. Neuroepidemiology. 34: 143-51. PMID 20090375 DOI: 10.1159/000275491 |
0.386 |
|
| 2010 |
Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Simon DK, Tarsy D, Hedera P, Truong DD, et al. Novel THAP1 sequence variants in primary dystonia. Neurology. 74: 229-38. PMID 20083799 DOI: 10.1212/Wnl.0B013E3181Ca00Ca |
0.509 |
|
| 2010 |
Criswell S, Sterling C, Swisher L, Evanoff B, Racette BA. Sensitivity and specificity of the finger tapping task for the detection of psychogenic movement disorders. Parkinsonism & Related Disorders. 16: 197-201. PMID 20005766 DOI: 10.1016/J.Parkreldis.2009.11.007 |
0.33 |
|
| 2010 |
Willis AW, Sterling C, Racette BA. Conjugal Parkinsonism and Parkinson disease: a case series with environmental risk factor analysis. Parkinsonism & Related Disorders. 16: 163-6. PMID 19818671 DOI: 10.1016/J.Parkreldis.2009.09.002 |
0.497 |
|
| 2009 |
Simón-Sánchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D, Paisan-Ruiz C, Lichtner P, Scholz SW, Hernandez DG, Krüger R, Federoff M, Klein C, Goate A, Perlmutter J, ... ... Racette BA, et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nature Genetics. 41: 1308-12. PMID 19915575 DOI: 10.1038/Ng.487 |
0.612 |
|
| 2009 |
Racette BA, Good LM, Kissel AM, Criswell SR, Perlmutter JS. A population-based study of parkinsonism in an Amish community. Neuroepidemiology. 33: 225-30. PMID 19641327 DOI: 10.1159/000229776 |
0.627 |
|
| 2009 |
Xiao J, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello RC, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Hedera P, Simon DK, Tarsy D, Truong DD, et al. High-throughput mutational analysis of TOR1A in primary dystonia. Bmc Medical Genetics. 10: 24. PMID 19284587 DOI: 10.1186/1471-2350-10-24 |
0.496 |
|
| 2009 |
Patra B, Parsian AJ, Racette BA, Zhao JH, Perlmutter JS, Parsian A. LRRK2 gene G2019S mutation and SNPs [haplotypes] in subtypes of Parkinson's disease. Parkinsonism & Related Disorders. 15: 175-80. PMID 18752982 DOI: 10.1016/J.Parkreldis.2008.05.004 |
0.631 |
|
| 2009 |
Galvin J, Burke W, Wang J, Racette B, Perlmutter J, Goate A. P3.029 Polymorphisms in aldehyde dehydrogenase and the risk of sporadic Parkinson disease Parkinsonism & Related Disorders. 15: S155. DOI: 10.1016/S1353-8020(09)70593-0 |
0.551 |
|
| 2008 |
Latourelle JC, Sun M, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts RL, Guttman M, Racette BA, Perlmutter JS, Ahmed A, Shill HA, et al. The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study. Bmc Medicine. 6: 32. PMID 18986508 DOI: 10.1186/1741-7015-6-32 |
0.615 |
|
| 2008 |
McNicoll CF, Latourelle JC, MacDonald ME, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts RL, Guttman M, Racette BA, Perlmutter JS, Ahmed A, et al. Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 1596-601. PMID 18649400 DOI: 10.1002/Mds.22186 |
0.629 |
|
| 2008 |
DeStefano AL, Latourelle J, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts R, Guttman M, Racette BA, Perlmutter JS, Marlor L, Shill HA, et al. Replication of association between ELAVL4 and Parkinson disease: the GenePD study. Human Genetics. 124: 95-9. PMID 18587682 DOI: 10.1007/S00439-008-0526-4 |
0.629 |
|
| 2008 |
Tobin JE, Latourelle JC, Lew MF, Klein C, Suchowersky O, Shill HA, Golbe LI, Mark MH, Growdon JH, Wooten GF, Racette BA, Perlmutter JS, Watts R, Guttman M, Baker KB, et al. Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology. 71: 28-34. PMID 18509094 DOI: 10.1212/01.Wnl.0000304051.01650.23 |
0.633 |
|
| 2008 |
Li Y, Grupe A, Rowland C, Holmans P, Segurado R, Abraham R, Jones L, Catanese J, Ross D, Mayo K, Martinez M, Hollingworth P, Goate A, Cairns NJ, Racette BA, et al. Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer's and Parkinson's disease. Human Molecular Genetics. 17: 759-67. PMID 18063669 DOI: 10.1093/Hmg/Ddm348 |
0.602 |
|
| 2007 |
Parsian AJ, Racette BA, Zhao JH, Sinha R, Patra B, Perlmutter JS, Parsian A. Association of α-synuclein gene haplotypes with Parkinson's disease Parkinsonism and Related Disorders. 13: 343-347. PMID 17292657 DOI: 10.1016/J.Parkreldis.2006.12.006 |
0.627 |
|
| 2007 |
Kieburtz K, Ravina B, Galpern WR, Tilley B, Shannon K, Tanner C, Wooten GF, Hamill R, Sage JI, Kosa E, Watts RL, Stover NR, McMurray R, Lew MF, Kawai C, ... ... Racette B, et al. A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease Neurology. 68: 20-28. PMID 17200487 DOI: 10.1212/01.Wnl.0000250355.28474.8E |
0.402 |
|
| 2007 |
Racette BA, Bradley A, Wrisberg CA, Perlmutter JS. Reply from the authors [6] Neurology. 69: 495-496. DOI: 10.1212/01.wnl.0000279165.72261.d0 |
0.351 |
|
| 2006 |
Wilk JB, Tobin JE, Suchowersky O, Shill HA, Klein C, Wooten GF, Lew MF, Mark MH, Guttman M, Watts RL, Singer C, Growdon JH, Latourelle JC, Saint-Hilaire MH, DeStefano AL, ... ... Racette BA, et al. Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD Study. Neurology. 67: 2206-10. PMID 17190945 DOI: 10.1212/01.Wnl.0000249149.22407.D1 |
0.619 |
|
| 2006 |
Racette BA, Bradley A, Wrisberg CA, Perlmutter JS. The impact of litigation on neurologic research. Neurology. 67: 2124-8. PMID 17190932 DOI: 10.1212/01.Wnl.0000249306.85048.86 |
0.461 |
|
| 2006 |
Sun M, Latourelle JC, Wooten GF, Lew MF, Klein C, Shill HA, Golbe LI, Mark MH, Racette BA, Perlmutter JS, Parsian A, Guttman M, Nicholson G, Xu G, Wilk JB, et al. Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study. Archives of Neurology. 63: 826-32. PMID 16769863 DOI: 10.1001/Archneur.63.6.826 |
0.554 |
|
| 2006 |
Weiss EM, Hershey T, Karimi M, Racette B, Tabbal SD, Mink JW, Paniello RC, Perlmutter JS. Relative risk of spread of symptoms among the focal onset primary dystonias. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 1175-81. PMID 16673404 DOI: 10.1002/Mds.20919 |
0.696 |
|
| 2006 |
Racette BA, Good L, Antenor JA, McGee-Minnich L, Moerlein SM, Videen TO, Perlmutter JS. [18F]FDOPA PET as an endophenotype for Parkinson's Disease linkage studies. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 141: 245-9. PMID 16528749 DOI: 10.1002/Ajmg.B.30293 |
0.604 |
|
| 2006 |
Racette BA, Tabbal SD, Jennings D, Good LM, Perlmutter JS, Evanoff BA. A rapid method for mass screening for parkinsonism. Neurotoxicology. 27: 357-61. PMID 16376428 DOI: 10.1016/J.Neuro.2005.11.005 |
0.574 |
|
| 2006 |
Racette BA, Perlmutter JS, Evanoff BA. Reply from the Authors [12] Neurology. 66: 617. DOI: 10.1212/01.Wnl.0000216108.57529.B1 |
0.424 |
|
| 2005 |
Karamohamed S, Latourelle JC, Racette BA, Perlmutter JS, Wooten GF, Lew M, Klein C, Shill H, Golbe LI, Mark MH, Guttman M, Nicholson G, Wilk JB, Saint-Hilaire M, DeStefano AL, et al. BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study. Neurology. 65: 1823-5. PMID 16344533 DOI: 10.1212/01.Wnl.0000187075.81589.Fd |
0.62 |
|
| 2005 |
Sinha R, Racette B, Perlmutter JS, Parsian A. Prevalence of parkin gene mutations and variations in idiopathic Parkinson's disease Parkinsonism and Related Disorders. 11: 341-347. PMID 16019250 DOI: 10.1016/J.Parkreldis.2005.04.003 |
0.619 |
|
| 2005 |
Karamohamed S, Golbe LI, Mark MH, Lazzarini AM, Suchowersky O, Labelle N, Guttman M, Currie LJ, Wooten GF, Stacy M, Saint-Hilaire M, Feldman RG, Liu J, Shoemaker CM, Wilk JB, ... ... Racette BA, et al. Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 1188-91. PMID 15966003 DOI: 10.1002/Mds.20515 |
0.618 |
|
| 2005 |
Racette BA, Tabbal SD, Jennings D, Good L, Perlmutter JS, Evanoff B. Prevalence of parkinsonism and relationship to exposure in a large sample of Alabama welders Neurology. 64: 230-235. PMID 15668418 DOI: 10.1212/01.Wnl.0000149511.19487.44 |
0.603 |
|
| 2005 |
Racette BA, Antenor JA, McGee-Minnich L, Moerlein SM, Videen TO, Kotagal V, Perlmutter JS. [18F]FDOPA PET and clinical features in parkinsonism due to manganism. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 492-6. PMID 15648057 DOI: 10.1002/Mds.20381 |
0.571 |
|
| 2004 |
Racette BA, Esper GJ, Antenor J, Black KJ, Burkey A, Moerlein SM, Videen TO, Kotagal V, Ojemann JG, Perlmutter JS. Pathophysiology of parkinsonism due to hydrocephalus. Journal of Neurology, Neurosurgery, and Psychiatry. 75: 1617-9. PMID 15489399 DOI: 10.1136/Jnnp.2003.028449 |
0.685 |
|
| 2004 |
Pastor P, Ezquerra M, Perez JC, Chakraverty S, Norton J, Racette BA, McKeel D, Perlmutter JS, Tolosa E, Goate AM. Novel haplotypes in 17q21 are associated with progressive supranuclear palsy. Annals of Neurology. 56: 249-58. PMID 15293277 DOI: 10.1002/Ana.20178 |
0.535 |
|
| 2004 |
Parsian A, Sinha R, Racette B, Zhao JH, Perlmutter JS. Association of a variation in the promoter region of the brain-derived neurotrophic factor gene with familial Parkinson's disease Parkinsonism and Related Disorders. 10: 213-219. PMID 15120095 DOI: 10.1016/J.Parkreldis.2003.12.003 |
0.61 |
|
| 2004 |
Parsian A, Racette B, Zhang ZH, Rundle M, Perlmutter JS. Association of variations in monoamine oxidases A and B with Parkinson's disease subgroups Genomics. 83: 454-460. PMID 14962671 DOI: 10.1016/J.Ygeno.2003.09.002 |
0.63 |
|
| 2003 |
Karamohamed S, DeStefano AL, Wilk JB, Shoemaker CM, Golbe LI, Mark MH, Lazzarini AM, Suchowersky O, Labelle N, Guttman M, Currie LJ, Wooten GF, Stacy M, Saint-Hilaire M, Feldman RG, ... ... Racette BA, et al. A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study. Neurology. 61: 1557-61. PMID 14663042 DOI: 10.1212/01.Wnl.0000095966.99430.F4 |
0.585 |
|
| 2003 |
Racette BA, Good L, Sagitto S, Perlmutter JS. Botulinum toxin B reduces sialorrhea in parkinsonism. Movement Disorders : Official Journal of the Movement Disorder Society. 18: 1059-61. PMID 14502678 DOI: 10.1002/Mds.10484 |
0.532 |
|
| 2002 |
Racette BA, Lopate G, Good L, Sagitto S, Perlmutter JS. Ptosis as a remote effect of therapeutic botulinum toxin B injection Neurology. 59: 1445-1447. PMID 12427903 DOI: 10.1212/Wnl.59.9.1445 |
0.458 |
|
| 2002 |
Racette BA, Hartlein JM, Hershey T, Mink JW, Perlmutter JS, Black KJ. Clinical features and comorbidity of mood fluctuations in Parkinson's disease. The Journal of Neuropsychiatry and Clinical Neurosciences. 14: 438-42. PMID 12426412 DOI: 10.1176/Jnp.14.4.438 |
0.799 |
|
| 2002 |
Racette BA, Stambuk M, Perlmutter JS. Secondary nonresponsiveness to new bulk botulinum toxin A (BCB2024). Movement Disorders : Official Journal of the Movement Disorder Society. 17: 1098-100. PMID 12360571 DOI: 10.1002/Mds.10209 |
0.447 |
|
| 2002 |
Racette BA, Rundle M, Wang JC, Goate A, Saccone NL, Farrer M, Lincoln S, Hussey J, Smemo S, Lin J, Suarez B, Parsian A, Perlmutter JS. A multi-incident, Old-Order Amish family with PD. Neurology. 58: 568-74. PMID 11865134 DOI: 10.1212/Wnl.58.4.568 |
0.636 |
|
| 2002 |
Parsian A, Racette B, Goldsmith LJ, Perlmutter JS. Parkinson's disease and apolipoprotein E: Possible association with dementia but not age at onset Genomics. 79: 458-461. PMID 11863377 DOI: 10.1006/Geno.2002.6707 |
0.632 |
|
| 2001 |
Racette BA, Perry A, D'Avossa G, Perlmutter JS. Late-onset neurodegeneration with brain iron accumulation type 1: Expanding the clinical spectrum Movement Disorders. 16: 1148-1152. PMID 11748751 DOI: 10.1002/Mds.10012 |
0.508 |
|
| 2001 |
Racette BA, Dowling J, Randle J, Mink JW. Thalamic stimulation for primary writing tremor. Journal of Neurology. 248: 380-2. PMID 11437158 DOI: 10.1007/S004150170177 |
0.482 |
|
| 2001 |
Racette BA, McGee-Minnich L, Moerlein SM, Mink JW, Videen TO, Perlmutter JS. Welding-related parkinsonism: clinical features, treatment, and pathophysiology. Neurology. 56: 8-13. PMID 11148228 DOI: 10.1212/Wnl.56.1.8 |
0.707 |
|
| 2000 |
Racette BA, Rich KM, Randle J, Mink JW. Ipsilateral thalamic stimulation after thalamotomy for essential tremor. A case report. Stereotactic and Functional Neurosurgery. 75: 155-9. PMID 11910208 DOI: 10.1159/000048400 |
0.487 |
|
| 2000 |
Racette BA, Rich KM, Randle J, Mink JW, Goto S, Hamasaki T, Nishikawa S, Okamura A, Yoshikawa M, Yamada K, Soyama N, Mita S, Ushio Y, Steinmeier R, Rachinger J, et al. Contents Vol. 75, 2000 Stereotactic and Functional Neurosurgery. 75: 205-205. DOI: 10.1159/000048408 |
0.432 |
|
| 2000 |
Racette BA, Rich KM, Randle J, Mink JW, Goto S, Hamasaki T, Nishikawa S, Okamura A, Yoshikawa M, Yamada K, Soyama N, Mita S, Ushio Y, Steinmeier R, Rachinger J, et al. Subject Index Vol. 75, 2000 Stereotactic and Functional Neurosurgery. 75: 204-204. DOI: 10.1159/000048407 |
0.465 |
|
| 1999 |
Racette BA, McGee-Minnich L, Perlmutter JS. Efficacy and safety of a new bulk toxin of botulinum toxin in cervical dystonia: A blinded evaluation Clinical Neuropharmacology. 22: 337-339. PMID 10626093 |
0.379 |
|
| 1999 |
Racette BA, Gokden MS, Tychsen LS, Perlmutter JS. Convergence insufficiency in idiopathic Parkinson's disease responsive to levodopa. Strabismus. 7: 169-74. PMID 10520242 DOI: 10.1076/Stra.7.3.169.636 |
0.545 |
|
| 1999 |
Racette BA, Rundle M, Parsian A, Perlmutter JS. Evaluation of a screening questionnaire for genetic studies of Parkinson's disease American Journal of Medical Genetics - Neuropsychiatric Genetics. 88: 539-543. PMID 10490713 DOI: 10.1002/(Sici)1096-8628(19991015)88:5<539::Aid-Ajmg19>3.0.Co;2-S |
0.636 |
|
| 1998 |
Parsian A, Racette B, Zhang ZH, Chakraverty S, Rundle M, Goate A, Perlmutter JS. Mutation, sequence analysis, and association studies of α-synuclein in Parkinson's disease Neurology. 51: 1757-1759. PMID 9855543 DOI: 10.1212/Wnl.51.6.1757 |
0.589 |
|
| 1998 |
Racette BA, Perlmutter JS. Levodopa responsive parkinsonism in an adult with Huntington's disease Journal of Neurology Neurosurgery and Psychiatry. 65: 577-579. PMID 9771791 DOI: 10.1136/Jnnp.65.4.577 |
0.58 |
|
| 1998 |
Black KJ, Racette B, Perlmutter JS. Preventing contractions in neuroleptic malignant syndrome and dystonia [2] American Journal of Psychiatry. 155: 1298-1299. PMID 9734560 DOI: 10.1176/Ajp.155.9.1298A |
0.601 |
|
| 1998 |
Racette BA, Lauryssen C, Perlmutter JS. Preoperative treatment with botulinum toxin to facilitate cervical fusion in dystonic cerebral palsy. Report of two cases Journal of Neurosurgery. 88: 328-330. PMID 9452245 DOI: 10.3171/Jns.1998.88.2.0328 |
0.46 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2015 |
Searles Nielsen S, Checkoway H, Criswell SR, Farin FM, Stapleton PL, Sheppard L, Racette BA. Inducible nitric oxide synthase gene methylation and parkinsonism in manganese-exposed welders. Parkinsonism & Related Disorders. 21: 355-60. PMID 25634431 DOI: 10.1016/J.Parkreldis.2015.01.007 |
0.298 |
|
| 2018 |
Searles Nielsen S, Gross A, Camacho-Soto A, Willis AW, Racette BA. β2-adrenoreceptor medications and risk of Parkinson disease. Annals of Neurology. PMID 30225948 DOI: 10.1002/ana.25341 |
0.296 |
|
| 2013 |
Romeo S, Viaggi C, Di Camillo D, Willis AW, Lozzi L, Rocchi C, Capannolo M, Aloisi G, Vaglini F, Maccarone R, Caleo M, Missale C, Racette BA, Corsini GU, Maggio R. Bright light exposure reduces TH-positive dopamine neurons: implications of light pollution in Parkinson's disease epidemiology. Scientific Reports. 3: 1395. PMID 23462874 DOI: 10.1038/Srep01395 |
0.288 |
|
| 2020 |
Camacho-Soto A, Gross A, Searles Nielsen S, Miller AN, Warden MN, Salter A, Racette BA. Fractures in the prodromal period of Parkinson disease. Neurology. PMID 32345729 DOI: 10.1212/WNL.0000000000009452 |
0.288 |
|
| 2011 |
Harris RC, Lundin JI, Criswell SR, Hobson A, Swisher LM, Evanoff BA, Checkoway H, Racette BA. Effects of parkinsonism on health status in welding exposed workers. Parkinsonism & Related Disorders. 17: 672-6. PMID 21724446 DOI: 10.1016/J.Parkreldis.2011.05.021 |
0.283 |
|
| 2012 |
Nelson G, Criswell SR, Zhang J, Murray J, Racette BA. Research capacity development in South African manganese mines to bridge exposure and neuropathologic outcomes. Neurotoxicology. 33: 683-6. PMID 22313906 DOI: 10.1016/J.Neuro.2012.01.003 |
0.282 |
|
| 2015 |
Morris M, Willis AW, Searles Nielsen S, McCann F, Birke A, Racette BA. Physician response to a medication alert system in inpatients with levodopa-treated diseases. Neurology. PMID 26092916 DOI: 10.1212/Wnl.0000000000001745 |
0.282 |
|
| 2018 |
Racette BA, Gross A, Vouri SM, Camacho-Soto A, Willis AW, Searles Nielsen S. Immunosuppressants and risk of Parkinson disease. Annals of Clinical and Translational Neurology. 5: 870-875. PMID 30009205 DOI: 10.1002/acn3.580 |
0.279 |
|
| 2011 |
Hobson A, Seixas N, Sterling D, Racette B. Estimation of particulate mass and Mn exposure levels among welders Occupational and Environmental Medicine. 68: A94-A95. DOI: 10.1136/Oemed-2011-100382.311 |
0.266 |
|
| 2014 |
Baker MG, Simpson CD, Stover B, Sheppard L, Checkoway H, Racette BA, Seixas NS. Blood manganese as an exposure biomarker: state of the evidence. Journal of Occupational and Environmental Hygiene. 11: 210-7. PMID 24579750 DOI: 10.1080/15459624.2013.852280 |
0.266 |
|
| 2015 |
Baker MG, Criswell SR, Racette BA, Simpson CD, Sheppard L, Checkoway H, Seixas NS. Neurological outcomes associated with low-level manganese exposure in an inception cohort of asymptomatic welding trainees. Scandinavian Journal of Work, Environment & Health. 41: 94-101. PMID 25380186 DOI: 10.5271/Sjweh.3466 |
0.262 |
|
| 2013 |
Racette BA, Gonzales, Nelson, Checkoway, Zhang. 232 Striatal pathology associated with chronic manganese exposure Occupational and Environmental Medicine. 70. DOI: 10.1136/Oemed-2013-101717.232 |
0.261 |
|
| 2009 |
Hobson AJ, Sterling DA, Emo B, Evanoff BA, Sterling CS, Good L, Seixas N, Checkoway H, Racette BA. Validity and reliability of an occupational exposure questionnaire for parkinsonism in welders. Journal of Occupational and Environmental Hygiene. 6: 324-31. PMID 19288335 DOI: 10.1080/15459620902836856 |
0.26 |
|
| 2011 |
Hobson A, Seixas N, Sterling D, Racette BA. Estimation of particulate mass and manganese exposure levels among welders. The Annals of Occupational Hygiene. 55: 113-25. PMID 20870928 DOI: 10.1093/Annhyg/Meq069 |
0.258 |
|
| 2015 |
Checkoway H, Nielsen SS, Racette BA. Environmental Exposures and Risks for Parkinson's Disease Environmental Factors in Neurodevelopmental and Neurodegenerative Disorders. 253-265. DOI: 10.1016/B978-0-12-800228-5.00012-1 |
0.254 |
|
| 2007 |
Willis AW, Crowner B, Brunstrom JE, Kissel A, Racette BA. High dose botulinum toxin A for the treatment of lower extremity hypertonicity in children with cerebral palsy. Developmental Medicine and Child Neurology. 49: 818-22. PMID 17979859 DOI: 10.1111/J.1469-8749.2007.00818.X |
0.254 |
|
| 2010 |
Crowner BE, Torres-Russotto D, Carter AR, Racette BA. Systemic weakness after therapeutic injections of botulinum toxin a: a case series and review of the literature. Clinical Neuropharmacology. 33: 243-7. PMID 20852412 DOI: 10.1097/Wnf.0B013E3181F5329E |
0.249 |
|
| 2000 |
Racette BA. Chorea and jaw-opening dystonia as a manifestation of NeuroBehcet's syndrome Movement Disorders. 15: 741-744. PMID 10928591 DOI: 10.1002/1531-8257(200007)15:4<741::Aid-Mds1025>3.0.Co;2-5 |
0.242 |
|
| 2015 |
Criswell SR, Nelson G, Gonzalez-Cuyar LF, Huang J, Shimony JS, Checkoway H, Simpson CD, Dills R, Seixas NS, Racette BA. Ex vivo magnetic resonance imaging in South African manganese mine workers. Neurotoxicology. 49: 8-14. PMID 25912463 DOI: 10.1016/J.Neuro.2015.04.002 |
0.24 |
|
| 2015 |
Low PA, Reich SG, Jankovic J, Shults CW, Stern MB, Novak P, Tanner CM, Gilman S, Marshall FJ, Wooten F, Racette B, Chelimsky T, Singer W, Sletten DM, Sandroni P, et al. Natural history study of MSA in North America: A prospective cohort study Autonomic Neuroscience: Basic and Clinical. 192: 126-127. DOI: 10.1016/J.Autneu.2015.07.231 |
0.236 |
|
| 2008 |
Crowner BE, Racette BA. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy. Pediatric Neurology. 39: 253-8. PMID 18805363 DOI: 10.1016/J.Pediatrneurol.2008.07.003 |
0.23 |
|
| 2007 |
Crowner BE, Brunstrom JE, Racette BA. Iatrogenic botulism due to therapeutic botulinum toxin a injection in a pediatric patient. Clinical Neuropharmacology. 30: 310-3. PMID 17909312 DOI: 10.1097/Wnf.0B013E31804B1A0D |
0.228 |
|
| 2018 |
Gross A, Racette BA, Camacho-Soto A, Dube U, Searles Nielsen S. Use of medical care biases associations between Parkinson disease and other medical conditions. Neurology. PMID 29743207 DOI: 10.1212/Wnl.0000000000005678 |
0.227 |
|
| 2004 |
Pastor P, Ezquerra M, Christian Perez J, Chakrataverty S, Norton J, Tolosa E, Racette BA, Goate AM. P4-160 Haplotype structure of the 17Q21 region in progressive supranuclear palsy and corticobasal degeneration Neurobiology of Aging. 25: S521. DOI: 10.1016/S0197-4580(04)81718-4 |
0.224 |
|
| 2015 |
Racette BA. Pre- and post-synaptic dopaminergic function in Mn-exposed humans Neurotoxicology and Teratology. 49: 148. DOI: 10.1016/J.Ntt.2015.04.153 |
0.222 |
|
| 2021 |
Camacho-Soto A, Faust I, Racette BA, Clifford DB, Checkoway H, Searles Nielsen S. Herpesvirus Infections and Risk of Parkinson's Disease. Neuro-Degenerative Diseases. 1-7. PMID 33461199 DOI: 10.1159/000512874 |
0.221 |
|
| 2014 |
Racette BA, Holtzman DM, Dall TM, Drogan O. Supply and demand analysis of the current and future US neurology workforce. Neurology. 82: 2254-5. PMID 24935638 DOI: 10.1212/Wnl.0000000000000509 |
0.22 |
|
| 2018 |
Camacho-Soto A, Searles Nielsen S, Racette BA. Inflammatory bowel disease and risk of Parkinson's disease in medicare beneficiaries. Parkinsonism & Related Disorders. PMID 29983328 DOI: 10.1016/j.parkreldis.2018.06.028 |
0.219 |
|
| 2021 |
Criswell SR, Nielsen SS, Dlamini WW, Warden MN, Perlmutter JS, Sheppard L, Moerlein SM, Lenox-Krug J, Checkoway H, Racette BA. Principal Component Analysis of Striatal and Extrastriatal D2 Dopamine Receptor Positron Emission Tomography in Manganese Exposed Workers. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 33881537 DOI: 10.1093/toxsci/kfab045 |
0.218 |
|
| 2006 |
Criswell SR, Crowner BE, Racette BA. The use of botulinum toxin therapy for lower-extremity spasticity in children with cerebral palsy. Neurosurgical Focus. 21: e1. PMID 16918222 DOI: 10.3171/Foc.2006.21.2.2 |
0.213 |
|
| 2021 |
Warden MN, Searles Nielsen S, Camacho-Soto A, Garnett R, Racette BA. A comparison of prediction approaches for identifying prodromal Parkinson disease. Plos One. 16: e0256592. PMID 34437600 DOI: 10.1371/journal.pone.0256592 |
0.213 |
|
| 2017 |
Searles Nielsen S, Hu SC, Checkoway H, Negrete M, Palmández P, Bordianu T, Racette BA, Simpson CD. Parkinsonism signs and symptoms in agricultural pesticide handlers in Washington State. Journal of Agromedicine. PMID 28418778 DOI: 10.1080/1059924X.2017.1317684 |
0.21 |
|
| 2014 |
Czuppon S, Racette BA, Klein SE, Harris-Hayes M. Variables associated with return to sport following anterior cruciate ligament reconstruction: a systematic review. British Journal of Sports Medicine. 48: 356-64. PMID 24124040 DOI: 10.1136/Bjsports-2012-091786 |
0.208 |
|
| 2003 |
Hou CE, Schlaggar BL, Racette BA. Dystonia in a patient with ring chromosome 21. Movement Disorders : Official Journal of the Movement Disorder Society. 18: 1547-9. PMID 14673898 DOI: 10.1002/Mds.10621 |
0.206 |
|
| 2012 |
Klein SE, Dale AM, Hayes MH, Johnson JE, McCormick JJ, Racette BA. Clinical presentation and self-reported patterns of pain and function in patients with plantar heel pain. Foot & Ankle International. 33: 693-8. PMID 22995253 DOI: 10.3113/Fai.2012.0693 |
0.202 |
|
| 2023 |
Song Y, Racette BA, Camacho-Soto A, Searles Nielsen S. Biologic targets of prescription medications and risk of neurodegenerative disease in United States Medicare beneficiaries. Plos One. 18: e0285011. PMID 37195983 DOI: 10.1371/journal.pone.0285011 |
0.199 |
|
| 2018 |
Searles Nielsen S, Racette BA. Author response: A predictive model to identify Parkinson disease from administrative claims data. Neurology. 91: 104. PMID 29987183 DOI: 10.1212/WNL.0000000000005767 |
0.198 |
|
| 2001 |
Racette BA. Welding-related Parkinsonism: Clinical features, treatment, and pathophysiology [1] Neurology. 57: 936-937. PMID 11575307 |
0.167 |
|
| 2019 |
Dlamini WW, Nelson G, Nielsen SS, Racette BA. Manganese exposure, parkinsonian signs, and quality of life in South African mine workers. American Journal of Industrial Medicine. PMID 31647574 DOI: 10.1002/ajim.23060 |
0.154 |
|
| 2010 |
Xiao J, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, Tarsy D, et al. Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6. Human Genetics. 127: 470. PMID 21488298 |
0.139 |
|
| 2010 |
Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, et al. Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6. Human Genetics. 127: 469-70. PMID 21488296 |
0.139 |
|
| 2010 |
Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, et al. Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6. Human Genetics. 127: 470. PMID 21488252 |
0.139 |
|
| 2019 |
Criswell SR, Nielsen SS, Warden MN, Flores HP, Lenox-Krug J, Racette S, Sheppard L, Checkoway H, Racette BA. MRI Signal Intensity and Parkinsonism in Manganese-Exposed Workers. Journal of Occupational and Environmental Medicine. PMID 31348423 DOI: 10.1097/Jom.0000000000001634 |
0.135 |
|
| 2019 |
Baker MG, Lin YS, Simpson CD, Shireman LM, Searles Nielsen S, Racette BA, Seixas N. The reproducibility of urinary ions in manganese exposed workers. Journal of Trace Elements in Medicine and Biology : Organ of the Society For Minerals and Trace Elements (Gms). 51: 204-211. PMID 30466932 DOI: 10.1016/J.Jtemb.2018.11.001 |
0.132 |
|
| 2016 |
Frank S, Testa CM, Stamler D, Kayson E, Davis C, Edmondson MC, Kinel S, Leavitt B, Oakes D, O'Neill C, Vaughan C, Goldstein J, Herzog M, Snively V, ... ... Racette BA, et al. Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial. Jama. 316: 40-50. PMID 27380342 DOI: 10.1001/Jama.2016.8655 |
0.124 |
|
| 2004 |
Smith JL, Ju JS, Saha BM, Racette BA, Fisher JS. Levodopa with carbidopa diminishes glycogen concentration, glycogen synthase activity, and insulin-stimulated glucose transport in rat skeletal muscle. Journal of Applied Physiology (Bethesda, Md. : 1985). 97: 2339-46. PMID 15258132 DOI: 10.1152/japplphysiol.01219.2003 |
0.098 |
|
| 2023 |
Criswell SR, Nielsen SS, Faust IM, Shimony JS, White RL, Lenox-Krug J, Racette BA. Neuroinflammation and White Matter Alterations in Occupational Manganese Exposure Assessed by Diffusion Basis Spectrum Imaging. Neurotoxicology. PMID 37127223 DOI: 10.1016/j.neuro.2023.04.013 |
0.09 |
|
| 2022 |
Camacho-Soto A, Searles Nielsen S, Faust IM, Bucelli RC, Miller TM, Racette BA. Incidence of amyotrophic lateral sclerosis in older adults. Muscle & Nerve. PMID 35678083 DOI: 10.1002/mus.27652 |
0.089 |
|
| 2023 |
Kreple CJ, Searles Nielsen S, Schoch KM, Shen T, Shabsovich M, Song Y, Racette BA, Miller TM. Protective effects of lovastatin in a population-based ALS study and mouse model. Annals of Neurology. PMID 36627836 DOI: 10.1002/ana.26600 |
0.083 |
|
| 2021 |
Dimitrova R, Kim H, Meilahn J, Chambers HG, Racette BA, Bonikowski M, Park ES, McCusker E, Liu C, Brin MF. Efficacy and safety of onabotulinumtoxinA with standardized physiotherapy for the treatment of pediatric lower limb spasticity: A randomized, placebo-controlled, phase III clinical trial. Neurorehabilitation. PMID 34957954 DOI: 10.3233/NRE-210070 |
0.066 |
|
| 2023 |
Faust I, Warden M, Camacho-Soto A, Racette BA, Searles Nielsen S. A predictive algorithm to identify ever smoking in medical claims-based epidemiologic studies. Annals of Epidemiology. PMID 37142065 DOI: 10.1016/j.annepidem.2023.04.019 |
0.035 |
|
| Hide low-probability matches. |